-+ 0.00%
-+ 0.00%
-+ 0.00%

Medibank Private And 2 Australian Dividend Stocks To Watch

Simply Wall St·10/18/2026 21:28:46
Listen to the news

Accelerating US inflation and rising volatility expectations are keeping many investors on edge. Australian dividend stocks offering yields above 3% with solid coverage and steady payout records can feel like a financial anchor when markets start to swing. This article walks through three income focused stocks from a high quality yield screen so you can see how reliable cash payouts might help balance a more unpredictable share market.

The three stocks highlighted here offer a compelling starting point if you want exposure to higher quality dividend payers with well covered, growing and stable income streams. However, if you want the absolute best, these 4 dividend aristocrats stocks are the cream of the crop.

Medibank Private (ASX:MPL)

Overview: Medibank Private is an Australian health insurer that earns recurring premiums from hospital and extras cover under its Medibank and ahm brands.

Operations: Medibank Private generates about A$8.6b from Health Insurance and A$634.8 million from Medibank Health, almost entirely within Australia.

Market Cap: A$13.1b

Medibank Private matters for this Dividend Powerhouses screen because its health insurance arm generates recurring premiums that support the regular payouts investors focus on.

"The expansion and scaling of primary care clinics, virtual health, and home care offerings position Medibank to benefit from the shift in consumer preferences toward preventative care and at-home healthcare, helping to differentiate its offering, limit claims inflation, and improve net margins."

The key factor for Medibank’s dividend appeal is what happens if a single pressure point subtly reshapes how much profit each policy earns.

That quiet shift in policy profitability sits at the center of the full narrative for Medibank Private, where you can see how claims trends, pricing power, and capital needs all intersect.

ASX:MPL Revenue & Expenses Breakdown as at Oct 2026
ASX:MPL Revenue & Expenses Breakdown as at Oct 2026

Monadelphous Group (ASX:MND)

Overview: Monadelphous Group provides engineering, construction and long-term maintenance services for heavy industrial, resources, energy and infrastructure projects, supporting contract-backed cash flows.

Operations: Monadelphous Group generates about A$1.37b from Engineering Construction and A$1.62b from Maintenance and Industrial Services, primarily in Australia.

Market Cap: A$2.86b

Monadelphous Group matters for the Dividend Powerhouses screen because recurring maintenance work and long-duration projects can turn large industrial contracts into relatively steady income streams that back a 3%+ yield.

"Accelerating investment in decarbonisation and renewable energy infrastructure is now translating into tangible contract wins and a growing pipeline, as evidenced by record awards secured by Zenviron and new high-voltage services capability."

The real tension for investors is whether one unseen shift in project mix and client concentration quietly changes how resilient those cash flows feel.

That quiet shift in client mix is exactly what the full narrative for Monadelphous Group unpacks, revealing where Monadelphous Group’s accelerating pipeline could mask or magnify future cash flow swings.

ASX:MND Revenue & Expenses Breakdown as at Oct 2026
ASX:MND Revenue & Expenses Breakdown as at Oct 2026

nib holdings (ASX:NHF)

Overview: nib holdings is a private health insurer whose Australian Residents Health Insurance arm provides recurring premiums that underpin its dividend, while international, travel and services units add diversified income.

Operations: nib holdings generates A$3.02b from Australian Residents Health Insurance, A$244.8 million from International Health Insurance, and A$431.8 million from New Zealand Insurance, with smaller contributions from travel, Thrive and health services.

Market Cap: A$3.18b

For income focused investors, nib holdings matters because its Australian Residents Health Insurance book throws off regular cash flow that can support a covered, growing dividend profile even as the rest of the group evolves.

"Expansion of health management and preventative care offerings (telehealth, wellbeing programs, in-home care, no/known gap networks) is broadening revenue streams, improving customer retention, and actively managing claims inflation, positively impacting both top-line growth and future claims ratios."

The real test will be how one unresolved shift in claims trends and policy lapses ultimately feeds through to nib holdings’ margins and dividend headroom.

That margin question is exactly what the full narrative for nib holdings tackles, mapping where accelerating care models could widen nib holdings’ dividend headroom or quietly cap future payout flexibility.

ASX:NHF Revenue & Expenses Breakdown as at Oct 2026
ASX:NHF Revenue & Expenses Breakdown as at Oct 2026

Seeking Fresh Alternatives Before They Fly

Markets move first, and headlines catch up later. Fresh ideas with real momentum are often noticed only once prices are already moving higher. Scan these curated lists before the broader crowd.

  • Target income that can weather shocks by reviewing a curated pool of resilient payers in the 4 dividend fortresses before yields change and prices move away.
  • Track early spending shifts toward automation with a focused list built around 91 robotics and automation stocks while valuations still reflect uncertainty rather than full conviction.
  • Consider critical infrastructure upgrades through a filtered group of 42 power grid technology and infrastructure stocks that may be influenced by changes in grid reliability spending.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.